Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects

Author(s):
Klumpers, L.E.; Fridberg, M.; Kam, M.L. de; Little, P.B.; Jensen, N.O.; Kleinloog, H.D.; Elling, C.E.; Gerven, J.M.A. van (0000-0002-1444-7415)
Published
2013
Publication type
Article / Letter to editor
cannabinoid receptor type 1 antagonistperipheral CB1 antagonistpharmacokineticsPK-PDrimonabantTM38837
Date issued
2013-12-31
Language
English
Is part of
British Journal of Clinical Pharmacology (2013), Vol. 76, no. 6, p. 846-857
hdl
1887/102499
doi
10.1111/bcp.12141